A Ardizzoia

Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.

Giulio Cerea, Massimo Vaghi, A Ardizzoia et al. · PubMed · 2003 · 96 citations

Medicine, Oncology, Pharmacology +16

Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.

A Ardizzoia, Paolo Lissoni, F Brivio et al. · PubMed · 1993 · 77 citations

Medicine, Oncology, Pathology +16

A RANDOMIZED STUDY OF TAMOXIFEN ALONE VERSUS TAMOXIFEN PLUS MELATONIN IN ESTROGEN RECEPTOR-NEGATIVE HEAVILY PRETREATED METASTATIC BREAST-CANCER PATIENTS

Paolo Lissoni, A Ardizzoia, Sandro Barni et al. · Oncology Reports · 1995 · 40 citations

Medicine, Endocrinology, Oncology +10

A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.

P. Lissoni, Massimo Vaghi, A Ardizzoia et al. · PubMed · 2003 · 29 citations

Medicine, Oncology, Pharmacology +17

Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer.

L. Frontini, Paolo Lissoni, Massimo Vaghi et al. · PubMed · 2005 · 27 citations

Medicine, Oncology, Pharmacology +12